Catherine Novack
Stock Analyst at Jones Trading
(1.49)
# 3,198
Out of 4,832 analysts
20
Total ratings
25%
Success rate
-8.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Maintains: Buy | $10 → $6 | $1.05 | +471.43% | 2 | May 13, 2025 | |
| RGLS Regulus Therapeutics | Downgrades: Hold | $8 → $7 | $7.84 | -10.71% | 2 | Apr 30, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.31 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $21.70 | +107.37% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.55 | +609.68% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $14.11 | +821.33% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $7.67 | +421.51% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.37 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.36 | +151.77% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $1.77 | +690.96% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.89 | +349.83% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.49 | +186.53% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.90 | +1,057.89% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.18 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.23 | +7,074.89% | 1 | Jul 21, 2023 |
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $1.05
Upside: +471.43%
Regulus Therapeutics
Apr 30, 2025
Downgrades: Hold
Price Target: $8 → $7
Current: $7.84
Upside: -10.71%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $21.70
Upside: +107.37%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.55
Upside: +609.68%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $14.11
Upside: +821.33%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $7.67
Upside: +421.51%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.37
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.36
Upside: +151.77%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $1.77
Upside: +690.96%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.89
Upside: +349.83%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.49
Upside: +186.53%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.90
Upside: +1,057.89%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.18
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.23
Upside: +7,074.89%